MwanzoM1RN34 • BVMF
add
Moderna Inc Bdr
Bei iliyotangulia
R$ 7.36
Bei za siku
R$ 7.05 - R$ 7.36
Bei za mwaka
R$ 6.22 - R$ 16.42
Thamani ya kampuni katika soko
10.44B USD
Wastani wa hisa zilizouzwa
elfu 59.99
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 142.00M | -41.08% |
Matumizi ya uendeshaji wa biashara | 230.00M | -14.18% |
Mapato halisi | -825.00M | 35.50% |
Kiwango cha faida halisi | -580.99 | -9.47% |
Mapato kwa kila hisa | -2.13 | 36.04% |
EBITDA | -850.00M | 35.70% |
Asilimia ya kodi ya mapato | -0.86% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 5.13B | -39.55% |
Jumla ya mali | 12.01B | -23.41% |
Jumla ya dhima | 2.61B | -34.20% |
Jumla ya hisa | 9.40B | — |
hisa zilizosalia | 389.08M | — |
Uwiano wa bei na thamani | 0.30 | — |
Faida inayotokana na mali | -18.35% | — |
Faida inayotokana mtaji | -21.65% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -825.00M | 35.50% |
Pesa kutokana na shughuli | -919.00M | 27.86% |
Pesa kutokana na uwekezaji | 564.00M | -65.80% |
Pesa kutokana na ufadhili | 9.00M | -73.53% |
Mabadiliko halisi ya pesa taslimu | -345.00M | -184.35% |
Mtiririko huru wa pesa | -664.50M | 33.39% |
Kuhusu
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
Sep 2010
Tovuti
Wafanyakazi
5,800
